# A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)

> **NCT04852705** · PHASE3 · UNKNOWN · sponsor: **Shenzhen Kangtai Biological Products Co., LTD** · enrollment: 28000 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** SARS-CoV-2 Vaccine (Vero Cells), Inactivated
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04852705
- **Lead sponsor:** Shenzhen Kangtai Biological Products Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05
- **Primary completion:** 2021-11
- **Final completion:** 2022-11
- **Target enrollment:** 28000 (ESTIMATED)
- **Last updated:** 2021-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04852705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04852705, "A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04852705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*